Denna sida har översatts automatiskt och översättningens korrekthet kan inte garanteras. Vänligen se engelsk version för en källtext.

Interprofessional Group Intervention to Promote Faculty Wellbeing and Engagement

10 mars 2020 uppdaterad av: Susan Hata, MD, Massachusetts General Hospital
A randomized trial of an interprofessional intervention to reduce burnout and enhance professional engagement in physicians, certified nurse midwives, and nurse practitioners.

Studieöversikt

Status

Avslutad

Betingelser

Intervention / Behandling

Detaljerad beskrivning

To test the hypothesis that an intervention involving self-facilitated interprofessional group meetings would result in improvement in wellbeing and to determine whether use of a written curriculum provided increased benefit, the following study is conducted:

Practicing clinical faculty in the Department of Obstetrics and Gynecology at the Massachusetts General Hospital were recruited to participate in three monthly small groups over dinner. Participants were randomized to a control group, which met without any specified guidelines for discussion content, or to receive an intervention which consisted of a one-page discussion guide addressing themes relevant to challenges in the healthcare environment: reframing challenging patient interactions; embracing uncertainty in work; and coping with errors, near misses, and bad outcomes. Outcomes included burnout, empowerment and engagement in work, stress from uncertainty assessed using validated metrics, and perception of of collegiality and community.

All participants were also offered the option of participating in evaluation of biomarkers. To test the hypothesis that an increased sense of bonding and relational connection, and reduced stress levels would be reflected by changes in hormone levels during the meeting and over the course of the study. Faculty who opted into this portion of the study gave the following samples:

Urine Oxytocin before and after the first and third group meetings Salivary Oxytocin before and after the first and third group meetings Salivary Cortisol before and after the first and third group meetings Hair Cortisol at the beginning of the study and at the end of the study (a roughly three month interval).

An optional focus group was conducted after the three monthly sessions.

All participants signed a consent form prior to participating in the study.

Studietyp

Interventionell

Inskrivning (Faktisk)

25

Fas

  • Inte tillämpbar

Kontakter och platser

Det här avsnittet innehåller kontaktuppgifter för dem som genomför studien och information om var denna studie genomförs.

Studieorter

  • Förenta staterna
    • Massachusetts
      • Boston, Massachusetts, Förenta staterna, 02114
        • Massachusetts General Hospital

Deltagandekriterier

Forskare letar efter personer som passar en viss beskrivning, så kallade behörighetskriterier. Några exempel på dessa kriterier är en persons allmänna hälsotillstånd eller tidigare behandlingar.

Urvalskriterier

Åldrar som är berättigade till studier

  • Barn
  • Vuxen
  • Äldre vuxen

Tar emot friska volontärer

Ja

Kön som är behöriga för studier

Allt

Beskrivning

Inclusion Criteria:

  • Physican in the Department of Obstetrics and Gynecology at Massachusetts General Hospital
  • Nurse Practitioner in the Department of Obstetrics and Gynecology at Massachusetts General Hospital
  • Certified Nurse Midwife in the Department of Obstetrics and Gynecology at Massachusetts General Hospital

Exclusion Criteria:

  • None

Studieplan

Det här avsnittet ger detaljer om studieplanen, inklusive hur studien är utformad och vad studien mäter.

Hur är studien utformad?

Designdetaljer

  • Primärt syfte: Övrig
  • Tilldelning: Randomiserad
  • Interventionsmodell: Parallellt uppdrag
  • Maskning: Enda

Vapen och interventioner

Deltagargrupp / Arm
Intervention / Behandling
Experimentell: Intervention
Providers were placed in small groups and given the intervention of a discussion guide to facilitate discussion.
Övrig: Discussion Guide
Written list of prompts to facilitate discussion
Inget ingripande: Control
Providers were placed in small groups and not given a discussion guide to facilitate discussion.

Vad mäter studien?

Primära resultatmått

Resultatmått
Åtgärdsbeskrivning
Tidsram
Burnout
Tidsram: Change over the three month study period. Baseline measurement and immediately after final intervention.

Change from baseline in 2 item Maslach Burnout Inventory scores before and after the intervention.

Minimum score: 2; Maximum score: 14 Higher score = more burnt out (worse outcome)
Change over the three month study period. Baseline measurement and immediately after final intervention.
Stress from Uncertainty
Tidsram: Change over the three month study period. Baseline measurement and immediately after final intervention.
Change in scores on Physician Response to Uncertainty Scale before and after intervention Minimum score: 6; Maximum score: 90 Higher score = increased stress due to uncertainty (worse outcome)
Change over the three month study period. Baseline measurement and immediately after final intervention.
Work Engagement
Tidsram: Change over the three month study period. Baseline measurement and immediately after final intervention.
Change in scores on Utrecht Work Engagement Scale before and after intervention Minimum score: 0; Maximum score: 54 Higher score = higher engagement at work (better outcome)
Change over the three month study period. Baseline measurement and immediately after final intervention.
Urine oxytocin
Tidsram: Two samples were taken one hour apart at baseline, and this was repeated three months later.
Change from baseline in the level of urine oxytocin before and after each intervention. This is an exploratory study so the maximum and minimum values are not known, and any change up or down is interesting.
Two samples were taken one hour apart at baseline, and this was repeated three months later.
Salivary Oxytocin
Tidsram: Two samples were taken one hour apart at baseline, and this was repeated three months later
Change from baseline in the level of salivary oxytocin before and after each intervention. This is an exploratory study so the maximum and minimum values are not known, and any change up or down is interesting.
Two samples were taken one hour apart at baseline, and this was repeated three months later
Salivary Cortisol
Tidsram: Two samples were taken one hour apart at baseline, and this was repeated three months later
Change from baseline in the level of salivary cortisol before and after each intervention. This is an exploratory study so the maximum and minimum values are not known, and any change up or down is interesting.
Two samples were taken one hour apart at baseline, and this was repeated three months later
Hair Cortisol
Tidsram: Change over the three month study period. Baseline measurement and immediately after final intervention.
Change from baseline in hair cortisol levels. Maximum and minimum levels are not known and any change up or down is interesting.
Change over the three month study period. Baseline measurement and immediately after final intervention.
Work Empowerment Scale
Tidsram: Change over the three month study period. Baseline measurement and immediately after final intervention.
Minimum score: 12; Maximum score: 84 Change from baseline on Work Empowerment Scale before and after intervention. Higher score = higher empowerment at work (better outcome)
Change over the three month study period. Baseline measurement and immediately after final intervention.

Samarbetspartners och utredare

Det är här du hittar personer och organisationer som är involverade i denna studie.

Sponsor

Massachusetts General Hospital

Studieavstämningsdatum

Dessa datum spårar framstegen för inlämningar av studieposter och sammanfattande resultat till ClinicalTrials.gov. Studieposter och rapporterade resultat granskas av National Library of Medicine (NLM) för att säkerställa att de uppfyller specifika kvalitetskontrollstandarder innan de publiceras på den offentliga webbplatsen.

Studera stora datum

Studiestart (Faktisk)

1 maj 2018

Primärt slutförande (Faktisk)

30 september 2018

Avslutad studie (Faktisk)

30 september 2018

Studieregistreringsdatum

Först inskickad

3 mars 2020

Först inskickad som uppfyllde QC-kriterierna

10 mars 2020

Första postat (Faktisk)

12 mars 2020

Uppdateringar av studier

Senaste uppdatering publicerad (Faktisk)

12 mars 2020

Senaste inskickade uppdateringen som uppfyllde QC-kriterierna

10 mars 2020

Senast verifierad

1 mars 2020

Mer information

Termer relaterade till denna studie

Ytterligare relevanta MeSH-villkor

Andra studie-ID-nummer

  • 2018P000415

Plan för individuella deltagardata (IPD)

Planerar du att dela individuella deltagardata (IPD)?

NEJ

Läkemedels- och apparatinformation, studiedokument

Studerar en amerikansk FDA-reglerad läkemedelsprodukt

Nej

Studerar en amerikansk FDA-reglerad produktprodukt

Nej

Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .

Prenumerera